SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $189,000 | +2.7% | 1,176 | -37.3% | 0.00% | 0.0% |
| Q1 2020 | $184,000 | -24.3% | 1,876 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $243,000 | +71.1% | 1,876 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $142,000 | -50.3% | 1,876 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $286,000 | +27.7% | 1,876 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $224,000 | +8.7% | 1,876 | -0.3% | 0.00% | -33.3% |
| Q4 2018 | $206,000 | -32.2% | 1,881 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $304,000 | +22.1% | 1,881 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $249,000 | +26.4% | 1,881 | -29.4% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | +33.1% | 2,664 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $148,000 | +25.4% | 2,664 | +2.5% | 0.00% | 0.0% |
| Q3 2017 | $118,000 | +34.1% | 2,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $88,000 | +8700.0% | 2,600 | +32400.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 8 | +14.3% | 0.00% | – |
| Q4 2015 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |